- 24/7 Wall St.•9 days ago
A couple companies made serious gains on Thursday after each reported a key approval by the U.S. Patent and Trademark Office.
- Marketwired•9 days ago
Akers Biosciences, Inc. , , a developer of rapid health information technologies, announces that the United States Patent and Trademark Office has allowed a patent covering Akers Bio's proprietary cartridge ...
- Marketwired•last month
Akers Biosciences, Inc. , , a developer of rapid health information technologies, today announces the closing of its previously announced underwritten public offering of 1,667,000 shares of common stock ...
AKR.L : Summary for AKERS BIOSCIENCES, INC. COM SHS - Yahoo Finance
Akers Biosciences, Inc. (AKR.L)
LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
|Bid||0.00 x 120000|
|Ask||0.00 x 120000|
|Day's Range||86.00 - 86.00|
|52 Week Range||86.00 - 255.00|
|PE Ratio (TTM)||-97.22|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|